Yahoo · Aug 20, 2026
What Are Wall Street Analysts' Target Price for Henry Schein Stock?
Henry Schein has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.
NASDAQ · HSIC
Henry Schein, Inc.
Healthcare · Medical - Distribution
$88.52
Down-$1.28 (-1.43%)
Updated Sep 2, 2026, 8:30 AM
SID Score
6.7/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 9.35B
- P/E ratio
- 23.9
- Dividend yield
- 0.00%
- 52-week range
- $68.70 – $92.18
- Volume
- 718.25K
- Avg. volume
- 1.51M
Price performance
HSIC price history
1M range · 21 trading sessions · Daily adjusted prices
HSIC closed at $88.52 after 21 trading sessions, down 0.66% for the selected period.
- Last close
- $88.52
- Period change
- -0.66%
- Period low
- $88.08
- Period high
- $90.74
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 1, 2026 | $89.80 | $90.15 | $88.00 | $88.52 | 718.25K |
| Aug 31, 2026 | $88.93 | $90.00 | $88.1638 | $89.80 | 1.15M |
| Aug 28, 2026 | $90.54 | $91.09 | $89.47 | $89.52 | 795.97K |
| Aug 27, 2026 | $90.30 | $91.39 | $89.605 | $90.28 | 784.93K |
| Aug 26, 2026 | $89.97 | $90.67 | $89.49 | $90.38 | 697.17K |
| Aug 25, 2026 | $89.19 | $89.84 | $88.74 | $89.65 | 819.51K |
| Aug 24, 2026 | $88.50 | $89.7102 | $87.67 | $89.51 | 669.18K |
| Aug 21, 2026 | $88.74 | $89.11 | $88.19 | $88.50 | 758.82K |
| Aug 20, 2026 | $89.00 | $89.69 | $88.405 | $88.46 | 865.71K |
| Aug 19, 2026 | $90.11 | $91.29 | $89.17 | $89.29 | 1.18M |
| Aug 18, 2026 | $89.94 | $90.455 | $88.73 | $89.23 | 1.03M |
| Aug 17, 2026 | $88.80 | $90.335 | $88.63 | $89.52 | 1.27M |
| Aug 14, 2026 | $90.09 | $90.67 | $89.46 | $89.77 | 1.16M |
| Aug 13, 2026 | $90.89 | $91.54 | $89.095 | $90.12 | 960.95K |
| Aug 12, 2026 | $88.945 | $90.93 | $88.47 | $90.74 | 1.04M |
| Aug 11, 2026 | $88.00 | $90.08 | $88.00 | $89.18 | 927.82K |
| Aug 10, 2026 | $87.57 | $88.37 | $87.47 | $88.08 | 1.4M |
| Aug 7, 2026 | $88.12 | $88.83 | $87.57 | $88.13 | 649.69K |
| Aug 6, 2026 | $90.03 | $90.32 | $87.735 | $88.23 | 1.16M |
| Aug 5, 2026 | $89.17 | $90.56 | $87.06 | $89.59 | 1.64M |
| Aug 4, 2026 | $90.99 | $92.18 | $87.34 | $89.11 | 3.36M |
Latest HSIC news
The latest Smart Investors Daily articles mentioning HSIC.
Stock researchCompany · Overview
HSIC research
Overview
Company profile and research snapshot.
Company profile
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $82.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | BTIG | Buy | — |
| Aug 6, 2026 | Barclays | Overweight | — |
| Aug 5, 2026 | Citigroup | Buy | — |
| Aug 5, 2026 | UBS | Neutral | — |
| Aug 5, 2026 | BTIG | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 19, 2026
BTIG Maintains Buy on Henry Schein, Raises Price Target to $110
BTIG analyst David Larsen maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises the price target from $100 to $110.
Yahoo · Aug 18, 2026
HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates
Henry Schein's stronger Q2 sales and margins prompt a 2026 outlook hike, but second-half savings execution remains key to sustaining earnings momentum.
Yahoo · Aug 18, 2026
3 Unpopular Stocks with Open Questions
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
